dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate

C56H68BrClF2K2N12O7 — CID 157072210

IUPACdipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate
SMILESC.C.C.CC1C(=O)N(C)Cc2c(Br)nc(C3CCOCC3)n21.Cc1cn(-c2cc3ccc(F)c(-c4nc(C5CCOCC5)n5c4CN(C)C(=O)C5C)c3cn2)cn1.Cc1cn(-c2cc3ccc(F)c(Cl)c3cn2)cn1.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C26H27FN6O2.C13H18BrN3O2.C13H9ClFN3.CH2O3.3CH4.2K.H/c1-15-12-32(14-29-15)22-10-18-4-5-20(27)23(19(18)11-28-22)24-21-13-31(3)26(34)16(2)33(21)25(30-24)17-6-8-35-9-7-17;1-8-13(18)16(2)7-10-11(14)15-12(17(8)10)9-3-5-19-6-4-9;1-8-6-18(7-17-8)12-4-9-2-3-11(15)13(14)10(9)5-16-12;2-1-4-3;;;;;;/h4-5,10-12,14,16-17H,6-9,13H2,1-3H3;8-9H,3-7H2,1-2H3;2-7H,1H3;1,3H;3*1H4;;;/q;;;;;;;2*+1;-1/p-1
InChIKeyQITZBWKUESOFJH-UHFFFAOYSA-M
MW1252.79 g/mol
LogP4.22
Rot. Bonds6

About dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate

dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate (PubChem CID 157072210) has the molecular formula C56H68BrClF2K2N12O7 and a molecular weight of 1252.79 g/mol. Its IUPAC name is dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate.

Molecular Properties

Compound Namedipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate
PubChem CID157072210
Molecular FormulaC56H68BrClF2K2N12O7
Molecular Weight1252.79 g/mol
Exact Mass1250.34
IUPAC Namedipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate
SMILESC.C.C.CC1C(=O)N(C)Cc2c(Br)nc(C3CCOCC3)n21.Cc1cn(-c2cc3ccc(F)c(-c4nc(C5CCOCC5)n5c4CN(C)C(=O)C5C)c3cn2)cn1.Cc1cn(-c2cc3ccc(F)c(Cl)c3cn2)cn1.O=CO[O-].[H-].[K+].[K+]
InChIInChI=1S/C26H27FN6O2.C13H18BrN3O2.C13H9ClFN3.CH2O3.3CH4.2K.H/c1-15-12-32(14-29-15)22-10-18-4-5-20(27)23(19(18)11-28-22)24-21-13-31(3)26(34)16(2)33(21)25(30-24)17-6-8-35-9-7-17;1-8-13(18)16(2)7-10-11(14)15-12(17(8)10)9-3-5-19-6-4-9;1-8-6-18(7-17-8)12-4-9-2-3-11(15)13(14)10(9)5-16-12;2-1-4-3;;;;;;/h4-5,10-12,14,16-17H,6-9,13H2,1-3H3;8-9H,3-7H2,1-2H3;2-7H,1H3;1,3H;3*1H4;;;/q;;;;;;;2*+1;-1/p-1
InChIKeyQITZBWKUESOFJH-UHFFFAOYSA-M
XLogP4.22
TPSA205.50 Ų
H-Bond Donors
H-Bond Acceptors17
Rotatable Bonds6
Heavy Atoms81
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001252.79
LogP ≤ 54.22
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}

Analyze dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(3,6-dihydro-2H-pyran-4-yl)-7-fluoroisoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(3,6-dihydro-2H-pyran-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;hydride;methane;oxido formate
CID 157319784
dipotassium;1-bromo-3-cyclopropyl-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(3,6-dihydro-2H-pyran-4-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-(3,6-dihydro-2H-pyran-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;hydride;methane;oxido formate
CID 158206491
Dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-(3-morpholin-4-ylisoquinolin-8-yl)-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate;4-[8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-3-yl]morpholine
CID 158643766
1-Bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5-(8-chloro-7-methylisoquinolin-3-yl)-2-methyl-1,3-thiazole;5,7-dimethyl-1-[7-methyl-3-(2-methyl-1,3-thiazol-5-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;methane
CID 158700489
Dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;5,7-dimethyl-1-[3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(4-methylimidazol-1-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate
CID 162126382

Frequently Asked Questions

What is the IUPAC name of dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate?
The IUPAC name of dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate (CID 157072210) is dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate.
What is the SMILES notation for dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate?
The canonical SMILES for dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate is C.C.C.CC1C(=O)N(C)Cc2c(Br)nc(C3CCOCC3)n21.Cc1cn(-c2cc3ccc(F)c(-c4nc(C5CCOCC5)n5c4CN(C)C(=O)C5C)c3cn2)cn1.Cc1cn(-c2cc3ccc(F)c(Cl)c3cn2)cn1.O=CO[O-].[H-].[K+].[K+].
What is the InChIKey of dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate?
The InChIKey is QITZBWKUESOFJH-UHFFFAOYSA-M. The full InChI is InChI=1S/C26H27FN6O2.C13H18BrN3O2.C13H9ClFN3.CH2O3.3CH4.2K.H/c1-15-12-32(14-29-15)22-10-18-4-5-20(27)23(19(18)11-28-22)24-21-13-31(3)26(34)16(2)33(21)25(30-24)17-6-8-35-9-7-17;1-8-13(18)16(2)7-10-11(14)15-12(17(8)10)9-3-5-19-6-4-9;1-8-6-18(7-17-8)12-4-9-2-3-11(15)13(14)10(9)5-16-12;2-1-4-3;;;;;;/h4-5,10-12,14,16-17H,6-9,13H2,1-3H3;8-9H,3-7H2,1-2H3;2-7H,1H3;1,3H;3*1H4;;;/q;;;;;;;2*+1;-1/p-1.
What are the key properties of dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate?
dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate has a molecular weight of 1252.79 g/mol, XLogP of 4.22, 6 rotatable bonds, 0 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for dipotassium;1-bromo-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;8-chloro-7-fluoro-3-(4-methylimidazol-1-yl)isoquinoline;1-[7-fluoro-3-(4-methylimidazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;oxido formate is sourced from PubChem (CID 157072210), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).